Elevance Health Current Ratio 2010-2024 | ELV
Current and historical current ratio for Elevance Health (ELV) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Elevance Health current ratio for the three months ending September 30, 2024 was 1.50.
| Elevance Health Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-09-30 | $62.85B | $42.03B | 1.50 |
| 2024-06-30 | $62.27B | $41.81B | 1.49 |
| 2024-03-31 | $60.95B | $44.33B | 1.38 |
| 2023-12-31 | $60.03B | $41.79B | 1.44 |
| 2023-09-30 | $61.19B | $43.34B | 1.41 |
| 2023-06-30 | $59.74B | $41.57B | 1.44 |
| 2023-03-31 | $59.82B | $41.89B | 1.43 |
| 2022-12-31 | $55.62B | $39.70B | 1.40 |
| 2022-09-30 | $55.60B | $41.29B | 1.35 |
| 2022-06-30 | $53.66B | $39.31B | 1.37 |
| 2022-03-31 | $53.90B | $39.73B | 1.36 |
| 2021-12-31 | $51.12B | $34.89B | 1.47 |
| 2021-09-30 | $51.90B | $35.16B | 1.48 |
| 2021-06-30 | $50.24B | $33.79B | 1.49 |
| 2021-03-31 | $54.50B | $34.75B | 1.57 |
| 2020-12-31 | $45.75B | $29.45B | 1.55 |
| 2020-09-30 | $45.45B | $28.56B | 1.59 |
| 2020-06-30 | $46.76B | $28.52B | 1.64 |
| 2020-03-31 | $41.26B | $27.04B | 1.53 |
| 2019-12-31 | $39.03B | $23.53B | 1.66 |
| 2019-09-30 | $39.50B | $23.23B | 1.70 |
| 2019-06-30 | $37.81B | $23.09B | 1.64 |
| 2019-03-31 | $36.61B | $22.68B | 1.61 |
| 2018-12-31 | $34.32B | $21.97B | 1.56 |
| 2018-09-30 | $37.11B | $24.17B | 1.54 |
| 2018-06-30 | $37.37B | $24.51B | 1.53 |
| 2018-03-31 | $36.97B | $24.76B | 1.49 |
| 2017-12-31 | $36.26B | $23.36B | 1.55 |
| 2017-09-30 | $36.97B | $24.41B | 1.52 |
| 2017-06-30 | $37.13B | $22.57B | 1.65 |
| 2017-03-31 | $37.98B | $23.17B | 1.64 |
| 2016-12-31 | $34.32B | $21.29B | 1.61 |
| 2016-09-30 | $32.92B | $21.04B | 1.57 |
| 2016-06-30 | $32.96B | $20.82B | 1.58 |
| 2016-03-31 | $32.97B | $20.81B | 1.58 |
| 2015-12-31 | $30.86B | $19.09B | 1.62 |
| 2015-09-30 | $31.54B | $18.37B | 1.72 |
| 2015-06-30 | $33.20B | $20.67B | 1.61 |
| 2015-03-31 | $34.74B | $21.31B | 1.63 |
| 2014-12-31 | $31.95B | $18.75B | 1.70 |
| 2014-09-30 | $32.23B | $18.40B | 1.75 |
| 2014-06-30 | $32.43B | $19.18B | 1.69 |
| 2014-03-31 | $31.81B | $18.49B | 1.72 |
| 2013-12-31 | $29.75B | $16.35B | 1.82 |
| 2013-09-30 | $29.60B | $16.04B | 1.85 |
| 2013-06-30 | $28.90B | $16.03B | 1.80 |
| 2013-03-31 | $28.66B | $16.03B | 1.79 |
| 2012-12-31 | $29.35B | $16.00B | 1.84 |
| 2012-09-30 | $29.64B | $14.08B | 2.11 |
| 2012-06-30 | $28.47B | $16.18B | 1.76 |
| 2012-03-31 | $27.54B | $15.96B | 1.73 |
| 2011-12-31 | $27.10B | $15.90B | 1.70 |
| 2011-09-30 | $27.55B | $15.79B | 1.75 |
| 2011-06-30 | $26.76B | $14.11B | 1.90 |
| 2011-03-31 | $26.82B | $14.16B | 1.89 |
| 2010-12-31 | $26.14B | $14.01B | 1.87 |
| 2010-09-30 | $26.94B | $14.14B | 1.91 |
| 2010-06-30 | $26.08B | $14.84B | 1.76 |
| 2010-03-31 | $27.12B | $14.81B | 1.83 |
| 2009-12-31 | $28.07B | $14.67B | 1.91 |
| 2009-09-30 | $25.36B | $14.13B | 1.80 |
| 2009-06-30 | $25.00B | $14.34B | 1.74 |
| 2009-03-31 | $12.48B | $15.34B | 0.81 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $84.995B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $43.734B | 16.44 |
| DiDi Global (DIDIY) | China | $22.941B | 0.00 |
| Natera (NTRA) | United States | $20.871B | 0.00 |
| ICON (ICLR) | Ireland | $16.879B | 15.03 |
| Viatris (VTRS) | United States | $14.478B | 4.46 |
| Avantor (AVTR) | United States | $14.307B | 21.45 |
| Revvity (RVTY) | United States | $13.453B | 23.37 |
| BioMerieux (BMXMF) | France | $12.659B | 0.00 |
| CochLear (CHEOY) | Australia | $11.807B | 0.00 |
| Solventum (SOLV) | United States | $11.540B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.417B | 29.35 |
| Doximity (DOCS) | United States | $10.302B | 60.64 |
| Charles River Laboratories (CRL) | United States | $9.314B | 18.00 |
| HealthEquity (HQY) | United States | $8.212B | 41.20 |
| Sonic Healthcare (SKHHY) | Australia | $8.208B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.322B | 29.43 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Sotera Health (SHC) | United States | $3.759B | 20.11 |
| Organon (OGN) | United States | $3.719B | 3.75 |
| BrightSpring Health Services (BTSG) | United States | $2.967B | 63.11 |
| Surgery Partners (SGRY) | United States | $2.493B | 28.42 |
| Concentras Parent (CON) | United States | $2.491B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.291B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.069B | 0.00 |
| Premier (PINC) | United States | $2.067B | 10.76 |
| PACS (PACS) | United States | $1.992B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.969B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.730B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.711B | 44.90 |
| Teladoc Health (TDOC) | United States | $1.544B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.224B | 11.98 |
| Progyny (PGNY) | United States | $1.208B | 24.47 |
| Embecta (EMBC) | United States | $1.161B | 8.12 |
| CareDx (CDNA) | United States | $1.102B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.090B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.874B | 5.91 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.775B | 0.00 |
| SBC Medicals (SBC) | United States | $0.649B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.492B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.478B | 0.00 |
| DocGo (DCGO) | United States | $0.444B | 16.73 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| Enhabit (EHAB) | United States | $0.387B | 33.48 |
| Sera Prognostics (SERA) | United States | $0.275B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.268B | 0.00 |
| LifeMD (LFMD) | United States | $0.212B | 0.00 |
| Biodesix (BDSX) | United States | $0.198B | 0.00 |
| Beauty Health (SKIN) | United States | $0.176B | 0.00 |
| Nutex Health (NUTX) | United States | $0.160B | 0.00 |
| ModivCare (MODV) | United States | $0.156B | 8.44 |
| MultiPlan (MPLN) | United States | $0.108B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.099B | 0.00 |
| So-Young (SY) | China | $0.093B | 15.69 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| OncoCyte (OCX) | United States | $0.037B | 0.00 |
| NeueHealth (NEUE) | United States | $0.033B | 0.87 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Oncology Institute (TOI) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |